Lecture image placeholder

Premium content

Access to this content requires a subscription. You must be a premium user to view this content.

Monthly subscription - $9.99Pay per view - $4.99Access through your institutionLogin with Underline account
Need help?
Contact us
Lecture placeholder background
VIDEO DOI: https://doi.org/10.48448/8qsh-9d44

technical paper

ENDO 2022

July 11, 2022

Atlanta, United States

Improvement of final height in congenital adrenal hyperplasia patients treated with recombinant growth hormone

Please log in to leave a comment

Downloads

Transcript English (automatic)

Next from ENDO 2022

HPA Axis Modulation by a Potent Inhibitor Indicates 11Beta-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Is a Significant Contributor to Cortisol Levels
technical paper

HPA Axis Modulation by a Potent Inhibitor Indicates 11Beta-Hydroxysteroid Dehydrogenase Type 1 (HSD-1) Is a Significant Contributor to Cortisol Levels

ENDO 2022

David Katz

11 July 2022

Similar lecture

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty
technical paper

Clinical, Hormonal and Genetic Characterization of Familial Central Precocious Puberty

ENDO 2022

Ana Canton

11 July 2022

Stay up to date with the latest Underline news!

Select topic of interest (you can select more than one)

PRESENTATIONS

  • All Lectures
  • For Librarians
  • Resource Center
  • Free Trial
Underline Science, Inc.
1216 Broadway, 2nd Floor, New York, NY 10001, USA

© 2023 Underline - All rights reserved